Under construction – not a live service
Sign in
Taking people in FranceNo phase

AI Analysis of Heart Ultrasound Scans in People With High Blood Pressure

Develops AI tools to study heart changes from routine ultrasound scans in adults with hypertension.

Key facts

Who runs it
Hospices Civils de Lyon
Where
Pierre-Bénite, FranceSee the site
Trial code
Registry title
Echocardiographic Analysis by Artificial Intelligence in Hypertension
Status
Recruiting
People taking part
200 people, planned
Started
1 Jun 2022
Planned end
31 Dec 2024
Type of study
Observational
Treatments tested
  • Clinical cardiac parameters (Arterial pressure, number of anti-hypertensive medications, and the NT-proBNP measurements)
Record updated
8 November 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who had a full blood pressure check during a hospital stay in the cardiology department at Croix Rousse Hospital or Lyon Sud Hospital between January 2018 and December 2021.

Age
18 years or older
Sex
All sexes can join.

Main reasons for not taking part

  • Minors
  • People under curatorship or guardianship

Where in France

  • Hopital Lyon SudPierre-Bénite, FranceContact: Pierre-Yves COURAND, MD, PhDTaking people

About the trial

What the trial wants to find out

The objective of this study is to develop artificial intelligence (AI) tools to characterize cardiac remodelling in arterial hypertension through the analysis of routine imaging data (echocardiography) coupled with patient data. More precisely, this study will make it possible (i) to represent in a relevant way the spectrum of the cardiac repercussions of a population affected by hypertension to better characterize the progress of the pathology, in particular vis-à-vis the more ambiguous subjects to be characterized ("grey" area); (ii) to develop tools for the automatic quantification of cardiac function (segmentation and robust monitoring of the myocardium during the cardiac cycle, for the dynamic analysis of the shape and global deformation of the heart) and therefore to extract descriptors richer in cardiac function than those currently used in clinical routine.

The group in the trial

  • Hypertensive patients

    Patients having undergone a blood pressure assessment during hospitalization in the Fédération de Cardiologie at Hôpital de la Croix Rousse and Hôpital Lyon Sud from January 2018 to December 2021

    Treatment: Clinical cardiac parameters (Arterial pressure, number of anti-hypertensive medications, and the NT-proBNP measurements)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Echocardiographic Analysis by Artificial Intelligence in Hypertension
Plain-language title
AI Analysis of Heart Ultrasound Scans in People With High Blood PressureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
8 November 2024